RxDoctor Payments Data

Joseph Evans, MD

Family Medicine · Chapin, SCNPI 1548277031

Payments from drug & device makers

$1,270in general payments, 2019–2025

Across 77 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$234
  • Novo Nordisk$192
  • Abbott$189
  • Sanofi-aventis U.S. LLC$119
  • Pfizer$115
  • Inari Medical, Inc.$91
  • plus $330 from 13 others

What the payments were for

  • Food & beverage$1,270100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,270 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$99,129
Medicare patients
281
Services billed
2,042

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide51$76,431
EliquisApixaban54$63,044
JardianceEmpagliflozin55$46,140
MounjaroTirzepatide25$27,828
JanuviaSitagliptin Phosphate22$24,128
RybelsusSemaglutide17$21,064
FarxigaDapagliflozin Propanediol32$16,242
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog29$14,802
TrulicityDulaglutide12$11,250
XareltoRivaroxaban14$10,784
Tolterodine Tartrate ErTolterodine Tartrate17$7,233
Atorvastatin Calcium313$4,050
SymbicortBudesonide/Formoterol Fumarate12$3,464
Losartan Potassium261$3,385
Amlodipine-ValsartanAmlodipine Besylate/Valsartan18$3,226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$192$97,49568 claims
PfizerEliquis$115$63,04454 claims
Boehringer IngelheimJardiance$33$46,14055 claims
Lilly USA, LLCMounjaro, Trulicity$26$39,07837 claims
AstraZenecaFarxiga, Symbicort$234$19,70544 claims
AbbVieSynthroid, Creon$18$3,61840 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Chapin

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →